CN101491527B - 四氢嘧啶在制备治疗肝炎或肝硬化药物中的应用 - Google Patents
四氢嘧啶在制备治疗肝炎或肝硬化药物中的应用 Download PDFInfo
- Publication number
- CN101491527B CN101491527B CN2009100146303A CN200910014630A CN101491527B CN 101491527 B CN101491527 B CN 101491527B CN 2009100146303 A CN2009100146303 A CN 2009100146303A CN 200910014630 A CN200910014630 A CN 200910014630A CN 101491527 B CN101491527 B CN 101491527B
- Authority
- CN
- China
- Prior art keywords
- liver
- hepatitis
- ectoine
- hepatocirrhosis
- tetrahydropyrimidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100146303A CN101491527B (zh) | 2009-03-03 | 2009-03-03 | 四氢嘧啶在制备治疗肝炎或肝硬化药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100146303A CN101491527B (zh) | 2009-03-03 | 2009-03-03 | 四氢嘧啶在制备治疗肝炎或肝硬化药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101491527A CN101491527A (zh) | 2009-07-29 |
CN101491527B true CN101491527B (zh) | 2011-05-25 |
Family
ID=40922430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100146303A Expired - Fee Related CN101491527B (zh) | 2009-03-03 | 2009-03-03 | 四氢嘧啶在制备治疗肝炎或肝硬化药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101491527B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103842508A (zh) * | 2011-06-21 | 2014-06-04 | 米纳治疗有限公司 | 白蛋白产生和细胞增殖 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102210683B (zh) * | 2011-04-29 | 2012-09-19 | 山东大学 | 四氢嘧啶及衍生物在制备预防和治疗青光眼药物中的应用 |
CN102423314A (zh) * | 2011-11-26 | 2012-04-25 | 济南环肽医药科技有限公司 | 一种治疗免疫性肝损伤或免疫性肝纤维化的药物 |
CN109468234A (zh) * | 2018-11-23 | 2019-03-15 | 浙江科技学院 | 一种羊肚菌原生质体的制备方法 |
-
2009
- 2009-03-03 CN CN2009100146303A patent/CN101491527B/zh not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103842508A (zh) * | 2011-06-21 | 2014-06-04 | 米纳治疗有限公司 | 白蛋白产生和细胞增殖 |
CN103842508B (zh) * | 2011-06-21 | 2016-02-24 | 米纳治疗有限公司 | 白蛋白产生和细胞增殖 |
Also Published As
Publication number | Publication date |
---|---|
CN101491527A (zh) | 2009-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhou et al. | Cascade two-stage tumor re-oxygenation and immune re-sensitization mediated by self-assembled albumin-sorafenib nanoparticles for enhanced photodynamic immunotherapy | |
Cornelis et al. | Update on potential medical treatments for encapsulating peritoneal sclerosis; human and experimental data | |
CN101491527B (zh) | 四氢嘧啶在制备治疗肝炎或肝硬化药物中的应用 | |
WO2016173486A1 (zh) | 曲美他嗪在制备防治肝病的药物中的用途 | |
RU2011139643A (ru) | Способ лечения неалкогольного стеатогепатита повышенными дозами урсодезоксихолевой кислоты | |
JP2020531030A5 (zh) | ||
EP2589382A1 (en) | Pharmaceutical composition comprising levocarnitine and dobesilate | |
KR20140025314A (ko) | 복합 조성물 | |
RU2009118962A (ru) | Применение антагонистов il-1 для лечения подагры и псевдоподагры | |
US20040043992A1 (en) | Meloxicam for alleviating organ injury during organ operation or transplantation | |
JP2006514665A5 (zh) | ||
EP2228068A1 (en) | Therapeutic agent for cerebral ischemic injury | |
EP2106791A1 (en) | Glutamine or glutamine-containing dipeptide in a specific dosage for the treatment of inflammation | |
JP2024504555A (ja) | 急性膵炎を予防及び治療するための薬物の製造におけるノルハルマンの使用 | |
CN108685907B (zh) | 防治肾损伤的化合物 | |
CN105267953B (zh) | Dll4细胞因子在制备治疗暴发性肝功能衰竭药剂中的应用 | |
CN105769851A (zh) | 一种治疗重症急性胰腺炎的药物组合物及其应用 | |
WO2014050912A1 (ja) | 二酸化炭素を溶解した液状医薬とそれを用いる治療方法 | |
CN105163750B (zh) | 长效人重组可溶性肿瘤坏死因子α受体在制备预防和治疗慢性肝病重症肝损伤药物中的用途 | |
JP2015520142A (ja) | 非経口エスモロール製剤 | |
CN110772507B (zh) | 盐酸胍作为治疗癌症/肿瘤的药物的用途 | |
Zhu et al. | Application value and challenge of traditional Chinese medicine carried by ZIF‐8 in the therapy of ischemic stroke | |
CN1297264C (zh) | 一种注射用洛索洛芬钠药物组合物 | |
US20100203146A1 (en) | Intermittent dosing strategy for treating rheumatoid arthritis | |
Jain et al. | Current practices in drug delivery for metabolic disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JINAN HUANTAI PHARMACEUTICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: SHANDONG UNIVERSITY Effective date: 20120929 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250014 JINAN, SHANDONG PROVINCE TO: 250100 JINAN, SHANDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120929 Address after: 250100 Shandong city of Ji'nan province high tech Zone Shun Road No. 750 University Science and Technology Park B zone 5 room 505 Patentee after: Jinan Huantai Pharmaceutical Technology Co., Ltd. Address before: 250014 pharmacological Institute of new medicine, School of pharmacy, Shandong University, 44 West Wenhua Road, Lixia District, Shandong, Ji'nan Patentee before: Shandong University |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110525 Termination date: 20170303 |
|
CF01 | Termination of patent right due to non-payment of annual fee |